Department of Reproductive Endocrinology, Zhejiang Provincial People's Hospital, Hangzhou Medical College, 310000, Hangzhou, P.R. China.
J Ovarian Res. 2021 Jul 15;14(1):94. doi: 10.1186/s13048-021-00844-7.
Laser-assisted hatching (LAH) has been widely applied to facilitate blastocyst hatching in IVF-ET treatment, however, the effect of LAH on subsequent development and clinical outcomes of the lower grade cleavage stage embryos (LGCE) remains unknown. Our study aimed at evaluating the effect of LAH on blastocyst formation and the clinical pregnancy outcomes of LGCE embryos after transfer.
A total of 608 cycles of IVF/ICSI treatment from November 2017 to September 2019 were included in our study as follows: 296 in the LAH group and 312 in the N-LAH group. The total blastocyst rate, usable blastocyst rate, good-grade blastocyst rate and clinical pregnancy rate were statistically compared between the two groups.
The total blastocyst rate (50.7% vs 40.2%, P < 0.001), usable blastocyst rate (31.0% vs 18.6%, P < 0.001) were significantly higher in the LAH group than those in the N-LAH group. After analysis of generalized estimating equations, LAH was positively correlated with the blastocyst rate (B = 0.201, OR 95% CI = 1.074-1.393, P = 0.002), usable blastocyst rate (B = 0.478, OR 95% CI = 1.331-1.955, P < 0.001). However, the clinical pregnancy rate after blastocyst transfer did not differ between LAH group and N-LAH group (49.4% vs 40.0%, P > 0.05, respectively).
A higher proportion of total blastocysts and usable blastocysts can be obtained by LAH in LGCE, which may be beneficial to the outcome of the IVF/ICSI-ET cycle.
激光辅助孵化(LAH)已广泛应用于体外受精-胚胎移植(IVF-ET)治疗中,以促进囊胚孵化,但 LAH 对低评分卵裂期胚胎(LGCE)后续发育和临床结局的影响尚不清楚。我们的研究旨在评估 LAH 对囊胚形成和移植后 LGCE 胚胎临床妊娠结局的影响。
纳入 2017 年 11 月至 2019 年 9 月共 608 个 IVF/ICSI 治疗周期,其中 LAH 组 296 个,非 LAH 组 312 个。比较两组间总囊胚率、可用囊胚率、优质囊胚率和临床妊娠率。
LAH 组总囊胚率(50.7% vs 40.2%,P<0.001)和可用囊胚率(31.0% vs 18.6%,P<0.001)均显著高于非 LAH 组。广义估计方程分析显示,LAH 与囊胚率呈正相关(B=0.201,OR 95%CI=1.074-1.393,P=0.002)和可用囊胚率(B=0.478,OR 95%CI=1.331-1.955,P<0.001)。然而,囊胚移植后的临床妊娠率在 LAH 组和非 LAH 组之间没有差异(分别为 49.4%和 40.0%,P>0.05)。
LAH 可提高 LGCE 中总囊胚和可用囊胚的比例,可能有利于 IVF/ICSI-ET 周期的结局。